2025-2026 Regular SessionPennsylvania Legislature

HB269: Further providing for drug overdose medication.

Legislative Summary

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

1/22/2025
Referred to HUMAN SERVICES
House of Representatives
3/17/2025
Reported as committed
House of Representatives
3/17/2025
First consideration
House of Representatives
3/17/2025
Laid on the table
House of Representatives
4/8/2025
Removed from table
House of Representatives
4/9/2025
Second consideration, with amendments
House of Representatives
4/9/2025
Re-committed to APPROPRIATIONS
House of Representatives
4/22/2025
Re-reported as committed
House of Representatives
4/22/2025
Third consideration and final passage (195-8)
House of Representatives

Amendments

House Amendment A00258 (PN 0214)

House Amendment A00258 (PN 0214)

Not Adopted

Roll Call Votes

House Floor: HB 269 PN 1331, FINAL PASSAGE
4/22/2025
195
Yea
8
Nay
0
Not Voting
0
Absent
Result: PASSED
House Appropriations: Re-report Bill As Committed
4/22/2025
37
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House Floor: HB 269 PN 214, 2025 A258
4/9/2025
203
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
House Human Services: Report Bill As Committed
3/5/2025
24
Yea
2
Nay
0
Not Voting
0
Absent
Result: PASSED